Literature DB >> 19539967

Characterization of a trimeric MPER containing HIV-1 gp41 antigen.

Andreas Hinz1, Guy Schoehn, Heribert Quendler, David Lutje Hulsik, Gabi Stiegler, Hermann Katinger, Michael S Seaman, David Montefiori, Winfried Weissenhorn.   

Abstract

The membrane-proximal external region (MPER) of gp41 is considered as a prime target for the induction of neutralizing antibodies, since it contains the epitopes for three broadly neutralizing antibodies (2F5, 4E10 and Z13). Here we present a novel gp41 construct (HA-gp41) comprising gp41 HR2 and MPER fused to two triple-stranded coiled-coil domains at both ends. HA-gp41 is trimeric, has a high helical content in solution and forms rod-like structures as revealed by negative staining electron microscopy. Immunization of rabbits with HA-gp41 induced antibodies directed against MPER, which failed to exert significant neutralization capacity against envelopes from primary isolates. Thus trimerisation of MPER regions does not suffice to induce a potent neutralizing antibody response specific for conserved regions within gp41.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19539967     DOI: 10.1016/j.virol.2009.05.015

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  17 in total

1.  Competition between Coiled-Coil Structures and the Impact on Myosin-10 Bundle Selection.

Authors:  Kevin C Vavra; Youlin Xia; Ronald S Rock
Journal:  Biophys J       Date:  2016-06-07       Impact factor: 4.033

2.  Structure of an HIV-1-neutralizing antibody target, the lipid-bound gp41 envelope membrane proximal region trimer.

Authors:  Patrick N Reardon; Harvey Sage; S Moses Dennison; Jeffrey W Martin; Bruce R Donald; S Munir Alam; Barton F Haynes; Leonard D Spicer
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

3.  Liposomal vaccines incorporating molecular adjuvants and intrastructural T-cell help promote the immunogenicity of HIV membrane-proximal external region peptides.

Authors:  Melissa C Hanson; Wuhbet Abraham; Monica P Crespo; Stephanie H Chen; Haipeng Liu; Greg Lee Szeto; Mikyung Kim; Ellis L Reinherz; Darrell J Irvine
Journal:  Vaccine       Date:  2015-01-02       Impact factor: 3.641

4.  Unidirectional Presentation of Membrane Proteins in Nanoparticle-Supported Liposomes.

Authors:  Wen Chen; Yongfei Cai; Qingshan Fu; Bing Chen; Junling Guo; James J Chou
Journal:  Angew Chem Int Ed Engl       Date:  2019-05-07       Impact factor: 15.336

5.  Antigenic characteristics of rhinovirus chimeras designed in silico for enhanced presentation of HIV-1 gp41 epitopes [corrected].

Authors:  Mauro Lapelosa; Gail Ferstandig Arnold; Emilio Gallicchio; Eddy Arnold; Ronald M Levy
Journal:  J Mol Biol       Date:  2010-02-04       Impact factor: 5.469

Review 6.  Immunising with the transmembrane envelope proteins of different retroviruses including HIV-1: a comparative study.

Authors:  Joachim Denner
Journal:  Hum Vaccin Immunother       Date:  2012-12-18       Impact factor: 3.452

7.  A fusion intermediate gp41 immunogen elicits neutralizing antibodies to HIV-1.

Authors:  Rachel P J Lai; Miriam Hock; Jens Radzimanowski; Paul Tonks; David Lutje Hulsik; Gregory Effantin; David J Seilly; Hanna Dreja; Alexander Kliche; Ralf Wagner; Susan W Barnett; Nancy Tumba; Lynn Morris; Celia C LaBranche; David C Montefiori; Michael S Seaman; Jonathan L Heeney; Winfried Weissenhorn
Journal:  J Biol Chem       Date:  2014-08-26       Impact factor: 5.157

8.  Immunogenic properties of a trimeric gp41-based immunogen containing an exposed membrane-proximal external region.

Authors:  Habtom H Habte; Saikat Banerjee; Heliang Shi; Yali Qin; Michael W Cho
Journal:  Virology       Date:  2015-10-09       Impact factor: 3.616

9.  Influences on trimerization and aggregation of soluble, cleaved HIV-1 SOSIP envelope glycoprotein.

Authors:  Per Johan Klasse; Rafael S Depetris; Robert Pejchal; Jean-Philippe Julien; Reza Khayat; Jeong Hyun Lee; Andre J Marozsan; Albert Cupo; Nicolette Cocco; Jacob Korzun; Anila Yasmeen; Andrew B Ward; Ian A Wilson; Rogier W Sanders; John P Moore
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

10.  A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 for neutralization but not for antigen recognition.

Authors:  David Lutje Hulsik; Ying-ying Liu; Nika M Strokappe; Simone Battella; Mohamed El Khattabi; Laura E McCoy; Charles Sabin; Andreas Hinz; Miriam Hock; Pauline Macheboeuf; Alexandre M J J Bonvin; Johannes P M Langedijk; David Davis; Anna Forsman Quigley; Marlén M I Aasa-Chapman; Michael S Seaman; Alejandra Ramos; Pascal Poignard; Adrien Favier; Jean-Pierre Simorre; Robin A Weiss; C Theo Verrips; Winfried Weissenhorn; Lucy Rutten
Journal:  PLoS Pathog       Date:  2013-03-07       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.